Medical Technology

@xconomy.com 3 years ago

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

@xconomy.com 4 years ago

Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More

@xconomy.com 4 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug

@xconomy.com 5 years ago

With New Data, Intercept On Track for First-Ever Approved NASH Drug

@xconomy.com 5 years ago

With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug

@xconomy.com 5 years ago

Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug